Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001437749-15-001946
Filing Date
2015-02-06
Accepted
2015-02-06 08:01:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A pdli20150205_sc13ga.htm SC 13G/A 71001
  Complete submission text file 0001437749-15-001946.txt   72778
Mailing Address 13859 PROGRESS BLVD. SUITE 100 ALACHUA FL 32615
Business Address 13859 PROGRESS BLVD. SUITE 100 ALACHUA FL 32615 (386) 462-6817
AxoGen, Inc. (Subject) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-38985 | Film No.: 15582049
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filed by) CIK: 0000882104 (see all company filings)

EIN.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2836 Biological Products, (No Diagnostic Substances)